h1

001007365 001__ 1007365
001007365 005__ 20250729052035.0
001007365 0247_ $$2HSB$$aeva574385
001007365 0247_ $$2ISSN$$a2072-6694
001007365 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85208379681
001007365 0247_ $$2WOS$$aWOS:001351059100001
001007365 0247_ $$2doi$$a10.3390/cancers16213647
001007365 0247_ $$2pmid$$apmid:39518085
001007365 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-253741
001007365 037__ $$aRWTH-CONV-253741
001007365 041__ $$aEnglish
001007365 1001_ $$0P:(DE-82)1015326$$aDreyer, Verena J.$$b0$$urwth
001007365 245__ $$aHigh Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable Prognosis$$honline
001007365 260__ $$c2024
001007365 300__ $$a[1]-16
001007365 3367_ $$00$$2EndNote$$aJournal Article
001007365 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001007365 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book
001007365 3367_ $$2BibTeX$$aARTICLE
001007365 3367_ $$2DRIVER$$aarticle
001007365 3367_ $$2DataCite$$aOutput Types/Journal article
001007365 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001007365 591__ $$aGermany
001007365 591__ $$aNetherlands
001007365 7001_ $$0P:(DE-82)1015327$$aShi, Jia-Xin$$b1$$urwth
001007365 7001_ $$0P:(DE-82)IDM06249$$aRose, Michael$$b2$$urwth
001007365 7001_ $$0P:(DE-82)1015325$$aOnyuro, Maureen T.$$b3$$urwth
001007365 7001_ $$0P:(DE-588)1211630528$$aSteib, Florian Leon$$b4$$urwth
001007365 7001_ $$0P:(DE-82)1015328$$aHilgers, Lars$$b5$$urwth
001007365 7001_ $$0P:(DE-82)842311$$aSeillier, Lancelot$$b6$$urwth
001007365 7001_ $$0P:(DE-82)1003670$$aDietrich, Jana$$b7$$urwth
001007365 7001_ $$0P:(DE-82)1015329$$aRiese, Janik$$b8$$urwth
001007365 7001_ $$0P:(DE-82)038116$$aMeurer, Steffen K.$$b9$$urwth
001007365 7001_ $$0P:(DE-82)IDM05726$$aWeiskirchen, Ralf$$b10$$urwth
001007365 7001_ $$aNeumann, Ulf$$b11
001007365 7001_ $$0P:(DE-588)1325969966$$aHeij, Lara$$b12$$urwth
001007365 7001_ $$aLuedde, Tom$$b13
001007365 7001_ $$aLoosen, Sven H.$$b14
001007365 7001_ $$aLurje, Isabella$$b15
001007365 7001_ $$aLurje, Georg$$b16
001007365 7001_ $$0P:(DE-82)IDM01362$$aGaisa, Nadine$$b17$$urwth
001007365 7001_ $$0P:(DE-82)IDM06181$$aJonigk, Danny David$$b18$$urwth
001007365 7001_ $$aBednarsch, Jan$$b19
001007365 7001_ $$0P:(DE-82)IDM06829$$aDahl, Edgar$$b20$$eCorresponding author$$urwth
001007365 7001_ $$0P:(DE-82)113237$$aOrtiz Brüchle, Nadina Carola$$b21$$urwth
001007365 770__ $$aClass 2 Tumor Suppressor Gene Pathways for Therapeutic Applications in Hard-to-Treat Cancers / Special Issue Editor: Prof. Dr. Edgar Dahl, Guest Editor
001007365 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers16213647$$n21$$p3647$$tCancers$$v16$$x2072-6694
001007365 8564_ $$uhttps://publications.rwth-aachen.de/record/1007365/files/1007365.pdf$$yOpenAccess
001007365 909CO $$ooai:publications.rwth-aachen.de:1007365$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
001007365 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001007365 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001007365 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001007365 9141_ $$y2024
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)1015326$$aRWTH Aachen$$b0$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)1015327$$aRWTH Aachen$$b1$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06249$$aRWTH Aachen$$b2$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)1015325$$aRWTH Aachen$$b3$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-588)1211630528$$aRWTH Aachen$$b4$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)1015328$$aRWTH Aachen$$b5$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)842311$$aRWTH Aachen$$b6$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)1003670$$aRWTH Aachen$$b7$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)1015329$$aRWTH Aachen$$b8$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)038116$$aRWTH Aachen$$b9$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM05726$$aRWTH Aachen$$b10$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-588)1325969966$$aRWTH Aachen$$b12$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM01362$$aRWTH Aachen$$b17$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06181$$aRWTH Aachen$$b18$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06829$$aRWTH Aachen$$b20$$kRWTH
001007365 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)113237$$aRWTH Aachen$$b21$$kRWTH
001007365 9201_ $$0I:(DE-82)528001-2_20140620$$k528001-2$$lInstitut und Lehrstuhl für Pathologie$$x0
001007365 9201_ $$0I:(DE-82)526000-3_20140620$$k526000-3$$lInstitut und Lehrstuhl für Molekulare Pathobiochemie, experimentelle Gentherapie und klinische Chemie$$x1
001007365 9201_ $$0I:(DE-82)528001-4_20140620$$k528001-4$$lLehr- und Forschungsgebiet Onkologische Pathologie$$x2
001007365 9201_ $$0I:(DE-82)528001-3_20140620$$k528001-3$$lLehr- und Forschungsgebiet Pathologie (Tumorpathologie)$$x3
001007365 961__ $$z2025-03-20
001007365 970__ $$aeva574385
001007365 980__ $$aI:(DE-82)526000-3_20140620
001007365 980__ $$aI:(DE-82)528001-2_20140620
001007365 980__ $$aI:(DE-82)528001-3_20140620
001007365 980__ $$aI:(DE-82)528001-4_20140620
001007365 980__ $$aUNRESTRICTED
001007365 980__ $$aVDB
001007365 980__ $$acontb
001007365 980__ $$ajournal
001007365 9801_ $$aFullTexts